Orphazyme

IPO

Copenhagen, Denmark · Founded 2009 · $34.0M raised

Headquarters
Copenhagen
Employees
51–200
Founded
2009
Business Model
B2B
Total Funding
$34.0M
Last Round
$20.0M Series BMar 2017
Rounds
2

About

Biopharmaceutical company developing novel therapeutics for rare diseases using heat-shock protein expertise.

Summary

Orphazyme is a Biotech company based in Copenhagen, Denmark, founded in 2009. It has raised $34.0M in total across 2 rounds, most recently a $20.0M Series B round in Mar 2017. Investors include Heartcore, Eurazeo and Kurma Partners.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionAcquisition by KemPharmMay 2022

Sign up to see all 4 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Orphazyme on Indexed.vc
<a href="https://indexed.vc/companies/orphazyme"><img src="https://indexed.vc/api/badge/company/orphazyme" alt="Orphazyme on Indexed.vc" width="260" height="76" /></a>